| 摘要 |
Phytoestrogenic pharmaceutical compositions having estrogen-like activity, comprising an active agent selected from licorice root extract, an isoflavanoid isolated from licorice root, particularly glabridin, hispaglabridin A, hispaglabridin B and glabrene, and any mixture thereof, and optionally further comprising a pharmaceutically acceptable carrier, excipient or diluent.The phytoestrogenic compositions of the invention are particularly suitable for the treatment and/or prevention of post-menopausal osteoporosis. and for hormone replacement post-menopausal therapy.
|
